Melissa - Director of Business Development

Increasing clinical provider sales by £37m - Director of Business Development
Melissa
Melissa is a truly remarkable Director of Business Development
Pharmaceutical

Find out more about this practitioner

Contact

Senior Consultant
+44 (0) 1491 577122

Melissa is a truly remarkable Director of Business Development with deep commercial experience across Pharma, Biotech, R&D academia and healthcare. Her impact on clients, such as CROs, has increased sales by more than 100%. She excels at providing a clear vision for growth opportunities and how to pursue them, delivering measurable benefit and securing new revenue streams.

A Clinical Services provider recently increased sales by £37million thanks to the assistance of Melissa. In what can only be described as an astonishing delivery, Melissa’s work over a three year period increased sales from £460k to £37.5m.

When Melissa arrived, the five-strong sales team had generated just £460k sales by month 10 of the fiscal year - just 2% of the £22m target. No-one in the team was maximising their existing relationships - in short, some of the team were simply not right for the role.

Melissa intensively reviewed which service offerings were being sold and in what way. She discovered that consultants had been spending too much time pitching cheaper, easier services in the hope that it would lead to more complex, valuable purchases. By working closely with them to build a personal, trusting relationship, she rebuilt their credibility in their network and oversaw the Operational side to ensure that faith remained in the quality of their service offering.

Studying pharma and biotech buying trends and the project managers at the company’s disposal, Melissa encouraged the Board and sales staff to focus their efforts in areas of strength, one of which being dermatology. Her decision paid instant dividends; she personally sold a phase 2 dermatology programme for £500k to demonstrate how success could be achieved.

Melissa conducted a workforce review of over 100 key people across Europe, discovering that certain project managers had hitherto unknown experience of running R &D dermatology groups. By sending them to potential clients alongside their operational duties, Melissa built the perfect CRO model.

Working across the company in this way, Melissa raised sales to £37.5m with a sales team of just eight people across Germany, France and the UK – covering the whole of Western Europe. 

“Melissa is an exceptional Business development director,” said the Executive Director of Global Contract Development. “By working in a smart, empathetic and pragmatic way, she is able achieve the best from individuals.  Melissa is focused on delivery but consistently goes the extra mile to get the result.”

Melissa has been described several times by clients as someone with an unrivalled ability to stand back and provide an objective and pragmatic view. Her work for this clinical data organisation is an excellent example. The strategy of the UK business unit had effectively stood still for 2 years. The aim of its parent company was for it to become a fully-fledged Clinical Research Organisation (CRO). While there was clear opportunity based on the organisation’s unique capabilities and assets, it had not been able to shape that opportunity into a viable service and customer value proposition.

One of the biggest obstacles was that the UK business was profitable in its current form. The need for change was seen as weak internally and sucked momentum away from attempts to crystallise the opportunity and develop a truly commercial proposition behind it. Melissa was engaged by the parent company to create and drive a targeted value proposition around the CRO market within short timescales (5 weeks).

Melissa’s analysis revealed that the organisation would be hard-pressed to compete against end-to-end CRO players for clinical trials or, indeed, in most areas. However, she identified late phase clinical trials, post drug approval, as an attractive and defendable area. The per patient budget was substantially lower in this area than for earlier phases but the higher volumes meant that an organisation with the right technology capabilities could minimise cost and command a strong competitive position and a revenue stream many times the size of its current business.

To overcome any further inertia within the organisation, Melissa shaped the proposition in detail with key stakeholders and conducted due diligence behind the service offering, skills and competencies required. She planned out a phased evolution that will enable this business to take manageable steps toward dominating this niche of the market – limiting investment risks, lowering the cost of the opportunity and growing the size of the revenue stream incrementally.

Fast Facts

  • 18 years commercial experience
  • Increased sales for a CRO from £460k to £37.5m within 3 years
  • Exceptional expertise for business development and assessment of value propositions
  • Due diligence of service offering, skills and competencies
  • Service cost & budget development
  • Versatile, enthusiastic and an ability to build robust business relationships
  • Positioning of service offering
  • Business and marketing planning
  • Positioning of service offering
  • Alignment of beneficial partnerships
  • Strategic business approaches
  • Alignment of beneficial partnerships
  • Commercial training
  • Expertise in service provider models, industry purchasing and procurement trends
"share